The Sagittarius Trial

NCT06490536 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Stage II
Colon Cancer Stage III

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Folinic acid
DRUG: Fluorouracil
DRUG: Temozolomide
DRUG: Irinotecan
DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Panitumumab

Sponsor

IFOM ETS - The AIRC Institute of Molecular Oncology